BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28466354)

  • 1. [Prevention and therapy of actinic keratoses].
    Gollnick Em HPM
    MMW Fortschr Med; 2017 May; 159(8):60-68. PubMed ID: 28466354
    [No Abstract]   [Full Text] [Related]  

  • 2. The current options in the management of actinic keratosis.
    Larkö O
    G Ital Dermatol Venereol; 2009 Aug; 144(4):445-52. PubMed ID: 19755948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Paugam C; Dréno B
    Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS31-IIS35. PubMed ID: 31133228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index.
    Schmitz L; Gupta G; Segert MH; Kost R; Sternberg J; Gambichler T; Stockfleth E; Dirschka T
    Skin Pharmacol Physiol; 2018; 31(4):206-211. PubMed ID: 29791916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Schmitt AR; Bordeaux JS
    Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermabrasion for prophylaxis and treatment of actinic keratoses.
    Coleman WP; Yarborough JM; Mandy SH
    Dermatol Surg; 1996 Jan; 22(1):17-21. PubMed ID: 8556252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal treatment of actinic keratoses.
    Uhlenhake EE
    Clin Interv Aging; 2013; 8():29-35. PubMed ID: 23345970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actinic keratosis. Patient-based approaches to adverse event management.
    Huang WW; Clark AR
    Adv NPs PAs; 2010 Dec; 1(4):31-2, 34-5, 48-9. PubMed ID: 21319451
    [No Abstract]   [Full Text] [Related]  

  • 10. Actinic keratosis. Current treatment options.
    Jeffes EW; Tang EH
    Am J Clin Dermatol; 2000; 1(3):167-79. PubMed ID: 11702298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review.
    Fleming P; Zhou S; Bobotsis R; Lynde C
    J Cutan Med Surg; 2017; 21(5):408-417. PubMed ID: 28510496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actinic Keratosis: Current Therapies and Insights Into New Treatments.
    Hashim PW; Chen T; Rigel D; Bhatia N; Kircik LH
    J Drugs Dermatol; 2019 May; 18(5):s161-166.. PubMed ID: 31141862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding efficacy end-points in studies of field-directed therapy for actinic keratosis.
    Wolf JE; Rigel DS
    Int J Dermatol; 2013 Sep; 52(9):1063-70. PubMed ID: 23962263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Actinic keratoses].
    Stockfleth E; Terhorst D; Hauschild A; Zouboulis CC; Schlaeger M; Oster-Schmidt C; Diepgen T; Garbe C; Gollnick H; Korting C; Merk H; Sterry W; Kerl H; Berking C
    J Dtsch Dermatol Ges; 2012 Dec; 10 Suppl 7():S1-23. PubMed ID: 23110516
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response.
    Rosen RH; Gupta AK; Tyring SK
    J Am Acad Dermatol; 2012 Mar; 66(3):486-93. PubMed ID: 22055282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-Based Practice Variations in Topical Treatment of Actinic Keratoses.
    Storer M; Zhu Z; Sokil M; Ford M; Neugebauer R; Asgari MM
    JAMA Dermatol; 2017 May; 153(5):468-470. PubMed ID: 28384712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues in the management of actinic keratosis.
    Ceilley RI; Jorizzo JL
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S28-38. PubMed ID: 23228304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinic keratosis: facts and controversies.
    Ko CJ
    Clin Dermatol; 2010; 28(3):249-53. PubMed ID: 20541675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of actinic keratosis].
    Isoherranen K; Koskenmies S; Overmark M; Ylitalo L; Saksela O; Pitkänen S
    Duodecim; 2015; 131(9):863-70. PubMed ID: 26237885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of erosive pustular dermatosis of the scalp occurring after topical 3.75% imiquimod for actinic keratoses.
    Giuffrida R; Borgia F; Cannavò SP
    Dermatol Ther; 2019 Jan; 32(1):e12770. PubMed ID: 30315627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.